Optimus Pharma to manufacture and market molnupiravir

The company has developed the API in house at its R&D center in Hyderabad

Indian Pharmaceutical Market grew at 6.6 pc in November

Flattish volume growth and subdued new launches were key factors for last month

Piramal Pharma takes a minority stake in Yapan Bio

The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space

Noorik Biopharma signs contract with Switzerland to develop ambrisentan to treat severe Covid-19

The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others

Six benefits of Cloud Computing in the pharma industry

NATCO Pharma to acquire Dash Pharmaceuticals

The cash consideration for the acquisition is US$ 18 million.

Lo.Li Pharma International seeks partners for Deplesin therapy

Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot

Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn

The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases

Zydus Pharmaceuticals USA receives tentative approval for schizophrenia drug

The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

Gland Pharma receives tentative approval for Cangrelor

Gland Pharma believes that they are amongst one of the first to file for this product and may be eligible for 180 days of generic drug exclusivity